Could Lannett Company, Inc. Lose Strenght? Option Traders Don’t Think So

 Could Lannett Company, Inc. Lose Strenght? Option Traders Don't Think So

In today’s session Lannett Company, Inc. (LCI) registered an unusually high (212) contracts volume of call trades. Someone, most probably a professional was a very active buyer of the March, 2017 call, expecting serious LCI increase. With 212 contracts traded and 1144 open interest for the Mar, 17 contract, it seems this is a quite bullish bet. The option with symbol: LCI170317C00035000 closed last at: $0.75 or 37.5% down. About 192,283 shares traded hands. Lannett Company, Inc. (NYSE:LCI) has risen 18.95% since March 16, 2016 and is uptrending. It has outperformed by 13.40% the S&P500.

Lannett Company, Inc. (NYSE:LCI) Ratings Coverage

Out of 8 analysts covering Lannett (NYSE:LCI), 6 rate it a “Buy”, 1 “Sell”, while 1 “Hold”. This means 75% are positive. $70 is the highest target while $3 is the lowest. The $42.07 average target is 92.10% above today’s ($21.9) stock price. Lannett has been the topic of 20 analyst reports since July 21, 2015 according to StockzIntelligence Inc. Canaccord Genuity downgraded Lannett Company, Inc. (NYSE:LCI) on Thursday, March 24 to “Sell” rating. The rating was upgraded by Zacks to “Strong-Buy” on Monday, September 7. Roth Capital maintained it with “Buy” rating and $68 target price in Thursday, September 3 report. Roth Capital maintained the stock with “Buy” rating in Wednesday, August 26 report. The firm has “Outperform” rating by Raymond James given on Wednesday, August 24. TH Capital maintained Lannett Company, Inc. (NYSE:LCI) rating on Thursday, September 3. TH Capital has “Buy” rating and $68.0 price target. On Wednesday, June 29 the stock rating was initiated by Deutsche Bank with “Hold”. Susquehanna initiated Lannett Company, Inc. (NYSE:LCI) on Tuesday, July 21 with “Positive” rating. Craig Hallum downgraded the stock to “Hold” rating in Thursday, November 5 report. The firm has “Buy” rating by Roth Capital given on Thursday, March 24.

According to Zacks Investment Research, “Lannett, Inc. manufactures and distributes pharmaceutical products sold under generic names and historically has manufactured and distributed pharmaceutical products sold under its trade or brand names. In addition, the Company contract manufactures and private labels pharmaceutical products for other companies.”

Insitutional Activity: The institutional sentiment increased to 0.88 in 2016 Q2. Its up 0.07, from 0.81 in 2016Q1. The ratio increased, as 38 funds sold all Lannett Company, Inc. shares owned while 51 reduced positions. 27 funds bought stakes while 51 increased positions. They now own 27.61 million shares or 4.85% less from 29.01 million shares in 2016Q1.
Walleye Trading Lc owns 200 shares or 0% of their US portfolio. Herndon Capital Ltd Liability holds 0% or 313 shares in its portfolio. Nationwide Fund accumulated 0.01% or 53,652 shares. Bb&T last reported 0.02% of its portfolio in the stock. Moreover, Sei Invests has 0% invested in Lannett Company, Inc. (NYSE:LCI) for 281 shares. Jpmorgan Chase And owns 265 shares or 0% of their US portfolio. Morgan Stanley last reported 267,825 shares in the company. Prudential Finance accumulated 0% or 84,688 shares. Great West Life Assurance Can last reported 2,000 shares in the company. Teachers has 0% invested in the company for 44,360 shares. Schwab Charles Invest Mngmt Incorporated has invested 0% of its portfolio in Lannett Company, Inc. (NYSE:LCI). Everpoint Asset Ltd Limited Liability Company accumulated 300,000 shares or 0.14% of the stock. Moreover, Rbf Llc has 0.19% invested in Lannett Company, Inc. (NYSE:LCI) for 40,000 shares. Savings Bank Of America De owns 80,816 shares or 0% of their US portfolio. Kcg Inc last reported 9,306 shares in the company.

Insider Transactions: Since August 31, 2016, the stock had 0 buys, and 3 insider sales for $416,823 net activity. Landis G. Michael had sold 6,786 shares worth $226,716. 1,478 Lannett Company, Inc. (NYSE:LCI) shares with value of $50,119 were sold by Maher James M..

Lannett Company, Inc. develops, manufactures, markets and distributes generic versions of brand pharmaceutical products. The company has a market cap of $852.73 million. The Firm makes and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. It has a 18.31 P/E ratio. As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules.

LCI Company Profile

Lannett Company, Inc., incorporated on December 3, 1991, develops, makes, markets and distributes generic versions of brand pharmaceutical products. The Firm makes and/or distributes prescription products with the exception of a small portfolio of over-the-counter products manufactured by its subsidiary, Silarx Pharmaceuticals, Inc. As of June 30, 2016, the Company’s products included Acetazolamide Tablets; Butalbital, Acetaminophen and Caffeine Tablets; Butalbital, Aspirin and Caffeine Capsules; C-Topical Solution; Digoxin Tablets; Glycolax Rx; Isosorbide Mononitrate CR; Levothyroxine Sodium Tablets; Methylphenidate HCL CD; Methylphenidate ER; Nifedipine CR; Omeprazole DR; Oxbutynin ER; Pantoprazole DR; Pilocarpine HCl Tablets; Triamterene w/Hydrochlorothiazide Capsules, and Ursodiol Capsules. The Firm has additional products under development, which are orally administered solid oral-dosage products (tablet/capsule) or oral solutions, nasal, topicals or parentarels, as well as other dosage forms.

Another recent and important Lannett Company, Inc. (NYSE:LCI) news was published by Fool.com which published an article titled: “Why Lannett Company, Inc. Shares Got Pummeled Today” on October 17, 2016.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

Tags: , ,

Related posts

Leave a Comment